References

Acupuncture Allergies Alzheimer's Disease Androgen Anxiety Disorders Asthma Atherosclerosis Attention Deficit Hyperactivity Disorder Bacterial Vaginosis Biofeedback Bipolar Disorder Birth Control Pills Blood Donation and Transfusion Breast Augmentation and Reduction Breast Cancer Breastfeeding Breast Reconstruction Caregiving Cervical Cancer Chiropractic Chlamydia Cholesterol Chronic Fatigue Syndrome Clinical Trials Colon Cancer Contraception Depression Diabetes Dry Eye Syndrome Eating Disorders Endometriosis Epilepsy Estrogen Fibroids Fibromyalgia Fitness Flu/Colds Gastroesophageal Reflux Disease (GERD) Genetic Testing Genital Herpes Glaucoma Gonorrhea Health Insurance Heart Disease Hepatitis High Blood Pressure HIV/AIDS Homeopathy Human Papillomavirus Hypnosis Hysterectomy Incontinence Infertility Irritable Bowel Syndrome Legal Health Tools Liposuction Lung Cancer Lupus Macular Degeneration Medication Safety Menopause Menstrual Disorders Metabolic Syndrome Migraine Multiple Sclerosis Naturopathy Nonsurgical Aesthetic Procedures Nutrition Obesity Ocular Allergies Oral Health Osteoarthritis Osteopathic Medicine Osteoporosis Ovarian Cancer Overactive Bladder Pain Management Pelvic Organ Prolapse Pelvic Pain Peripheral Arterial Disease Polycystic Ovary Syndrome Pregnancy Premenstrual Syndrome Preparing for Surgery Progesterone Rheumatoid Arthritis Schizophrenia Scleroderma Sexual Dysfunction Sinusitis Sjogren's Syndrome Skin Cancer Skin Health Sleep Disorders Smoking Stress Stroke Substance Abuse Tai Chi Teen Health Thyroid Disorders Trichomoniasis Urinary Tract Conditions Urinary Tract Infection Uterine Cancer Varicose Veins Violence Against Women Vulvodynia Weight Management Yeast Infections Yoga

"Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines." Grundy, Scott M; Cleeman, James I; Bairey Merz, C. Noel; et al. Circulation. 2004; 0:227-239. National Heart, Lung and Blood Institute and the American Heart Association.11 Available at: http://www.circulationaha.org. Accessed Sept. 2004.

"American Heart Association Guidelines for Primary Prevention of Atherosclerotic Cardiovascular Disease Beginning in Childhood." Circulation. 2003; 107:1562-1566. American Heart Association. Available at: http://www.circulationaha.org. Accessed Sept. 2004.

Cholesterol in Childhood. Pediatrics. 1998 Jan; 101(Pt 1):141-7. American Academy of Pediatrics Committee on Nutrition. American Academy of Pediatrics.

"FDA Plans to Evaluate Results of Women's Health Initiative Study for Estrogen-Alone Therapy." U.S. Food and Drug Administration. "FDA Talk Paper." March 2, 2004. http://www.fda.gov. Accessed March 2004.

American Heart Association. Heart Disease and Stroke Statistics--2004 Update. Dallas, TX: American Heart Association. 2003

Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ; National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003 May 21;289(19):2560-72. Epub 2003 May 14. Erratum in: JAMA. 2003 Jul 9;290(2):197.

Diabetes Creates Serious Cardiovascular Risk. American Diabetes Association. June 17, 2002. http://www.diabetes.org. Accessed January 2004.

Doctor, patient dialogue may help prevent serious complications of diabetes. American Diabetes Association. Nov. 17, 2003. http://www.diabetes.org. Accessed January 2004.

Effects of Estrogen plus Progestin on Health-Related Quality of Life. J. Hays et al. NEJM, May 8,2003; Vol. 348, No. 19.

FDA Approves new Labels for Estrogen and Estrogen with Progestin Therapies for Postmenopausal Women Following Review of Women's Health Initiative Data. FDA Talk Paper. Jan. 8, 2003

Grady D, Herrington D, Bittner V, et al, for the HERS Research Group. Heart and estrogen/progestin replacement study follow-up (HERS II): Part 1. Cardiovascular outcomes during 6.8 years of hormone therapy. JAMA 2002;288:49-57.

Gu K, Cowie CC, Harris MI. Diabetes and decline in heart disease mortality in US adults. JAMA 1999; 281:1291-7.

Hulley S, Furberg C, Barrett-Connor E, et al, for the HERS Research Group. Heart and estrogen/progestin replacement study follow-up (HERS II): Part 2. Non-cardiovascular outcomes during 6.8 years of hormone therapy. JAMA 2002;288:58-66.

The Link Between Diabetes and Cardiovascular Disease. National Diabetes Education Program. April 2002. http://www.diabetes.org. Accessed January 2004.

McSweeney JC, Cody M, O'Sullivan P, Elberson K, Moser DK, Garvin BJ. Women's early warning symptoms of acute myocardial infarction. Circulation. 2003 Nov 25;108(21):2619-23. Epub 2003 Nov 03 Canto JG, Iskandrian AE. Major risk factors for cardiovascular disease: debunking the "only 50%" myth. JAMA. 2003 Aug 20;290(7):947-9.

MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. The Lancet. Volume 361, Number 9374, 14 June 2003.

Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002; 288:321-333.

"Estrogen Plus Progestin Study Stopped Due to Increased Breast Cancer Risk, Lack of Overall Benefit." National Heart, Lung and Blood Institute. http://www.nhlbi.nih.gov. Updated July 9, 2002; accessed July 9, 2002.

"Women's Health Initiative," National Heart, Lung and Blood Institute. http://www.nhlbi.nih.gov. Updated July 9, 2002; accessed July 9, 2002.

"Fish and Omega-3 Fatty Acid Intake and Risk of Coronary Heart Disease in Women" Journal of the American Medical Association. Vol. 287 No. 14, April 10, 2002. http://jama.ama-assn.org. Accessed April 2002.

"FDA and EPA Announce the Revised Consumer Advisory on Methylmercury in Fish." U.S. Department of Health and Human Services and U.S. Environmental Protection Agency. March 19, 2004. Available at: http://www.fda.gov. Accessed Oct. 2004.

"Atherosclerosis." National Women's Health Information Center. Office on Women's Health. U.S. Dept. of Health and Human Services. Updated Oct. 2002. http://www.4woman.gov. Accessed Accessed May 2003.

"Coronary Artery Disease -- Printer Friendly Version" National Women's Health Information Center. Office on Women's Health. U.S. Dept. of Health and Human Services. Updated Oct. 2002. http://www.4woman.gov. Accessed May. 2003.

"Heart Disease and Stroke Statistics 2003 Update" The American Heart Association. http://www.americanheart.org. Accessed May 2003.

"Risk Factors and Heart Disease." American Heart Association. 2002. http://www.americanheart.org. Accessed May 2003.

"Heart Healthy Diet: Daily Food Guide Food Groups." National Cholesterol Education Program. National Heart, Lung and Blood Institute http://www.nhlbisupport.com. Accessed May 2003.

"Third Report of the NCEP Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults." Executive Summary. Journal of the American Medical Association, May 16, 2001.

"AHA/CDC panel issues recommendations on CRP testing" American Heart Association" Jan. 28, 2003. http://www.americanheart.org. Accessed May 28, 2003.

"New Diagnostic Test for Chest Pain Predicts Cardiac Risk Up to Six Months Ahead." Cleveland Clinic Heart Center. Oct. 23, 2003. http://www.clevelandclinic.org. Accessed Dec. 2003.

"FDA Approves Drug-Eluting Stent for Clogged Heart Arteries" FDA News. April 24, 2003. http://www.fda.gov. Accessed Dec. 2003.

Scott LA, Ben-Or K, Allen JK.. Why are women missing from outpatient cardiac rehabilitation programs? A review of multilevel factors affecting referral, enrollment, and completion. J Womens Health (Larchmt). 2002 Nov;11(9):773-91. Review.

Mosca L, Appel LJ, Benjamin EJ, -et al.Evidence-based guidelines for cardiovascular disease prevention in women. Circulation. 2004 Feb 10;109(5):672-93.

Hackam DG, Anand SS. Emerging risk factors for atherosclerotic vascular disease: a critical review of the evidence. JAMA. 2003 Aug 20;290(7):932-40. Review.

Canto JG, Iskandrian AE. Major risk factors for cardiovascular disease: debunking the "only 50%" myth. JAMA. 2003 Aug 20;290(7):947-9.

Hayden M, Pignone M, Phillips C, Mulrow C. Aspirin for the primary prevention of cardiovascular events: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2002 Jan 15;136(2):161-72.

Aspirin for the Primary Prevention of Cardiovascular Events – Chemoprevention. US Preventive Services Task Force. 2002.

AHA Scientific Statement: AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update, #71-0226 Circulation. 2002;106:388-91.

Statement from Elizabeth G. Nabel, M.D., Director of the National Heart, Lung, and Blood Institute of the National Institutes of Health on the Findings of the Women's Health Study. [press release]. Washington, DC: National Heart, Lung, and Blood Institute; March 7, 2005.

Peters RJ, Mehta SR, Fox KA, et al. Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) Trial Investigators. Effects of aspirin dose when used alone or in combination with clopidogrel in patients with acute coronary syndromes: observations from the Clopidogrel in unstable angina to prevent recurrent events (CURE) study. Circulation. 2003 Oct 7;108(14):1682-7. Epub 2003 Sep 22.

Gunnar RM, Bourdillon PD, Dison DW, et al. Guidelines for the early management of patients with acute myocardial infarction. A Report of the American College of Cardiology/American Heart Association Task Force Assessment of Diagnostic and Therapeutic Procedures (a subcommittee to develop guidelines for the early management of patients with myocardial infarction). Circulation. 1990;82:664-707.

AHA/ACC Guidelines for Preventing Heart Attack and Death in Patients With Atherosclerotic Cardiovascular Disease: 2001 Update, #71-0214 Circulation. 2001;104:1577-1579.

Scientists Examine Long-Term Risks and Gains of Pain Killers, New York Times. January 22, 2002.

Daily Aspirin Therapy. FDA Consumer magazine. US Food and Drug Administration. September-October 2003. http://www.fda.gov. Accessed January 23, 2005.

Mechcatie E. FDA panel rejects expanded label for aspirin: some support for nonfatal MI indication. OB/GYN News. January 1, 2004.

"American College of Cardiology and American Heart Association Advisory." American College of Cardiology Foundation. March 12, 2002. http://www.acc.org. Accessed December, 2005.

"American Council on Exercise." 2005. http://www.acefitness.org. Accessed December 2005.

"CK: Common questions." Lab Tests Online. January 26, 2005. http://labtestsonline.org. Accessed December 2005.

"Heart Attack Symptoms and Warning Signs." American Heart Association. 2005. www.americanheart.org. Accessed December 2005.

"Cardiac Syndrome X." The Texas Heart Institute at St. Lukes Episcopal Hospital. August 2005. http://www.tmc.edu. Accessed December 2005.

"The Benefits Of Eating Fish Greatly Outweigh The Risks, New Study Shows." Medical News Today. October 18, 2006. http://www.medicalnewstoday.com. Accessed October 2006.

"Updated guidelines advise focusing on women's lifetime heart risk." The American Heart Association. February 2007. http://www.americanheart.org. Accessed February 2007.